[Consensus clinical practice guidelines of the Andalusian Epilepsy Society on prescribing generic antiepileptic drugs].
BACKGROUND
Pharmaceutical spending in Spain accounts for 1.2-1.4% of the gross domestic product and is increasing by 5-12% per year. One of the measures adopted by the government to cut this spending is the possible substitution of original prescribed drugs by generics. In the case of antiepileptic drugs (AED), which are characterised by a scant therapeutic margin, these steps have sparked a scientific debate about their repercussion on the control of epileptic patients. We propose to draw up a set of implicit evidence-based consensus practice guidelines concerning issues related with this topic.


METHODS
A selective search for quality scientific information on the subject was conducted on PubMed-Medline, Tripdatabase and the Biblioteca Cochrane Plus. The selected references were analysed and discussed by the authors, and the recommendations deriving from them were collected. A total of 21 primary documents and 16 practice guidelines, protocols or experts' recommendations were identified. Our recommendations were explicitly included at the end of the text.


CONCLUSIONS
The Andalusian Epilepsy Society makes the following recommendations: 1) not replacing an innovative AED by its generic in a controlled patient; 2) beginning treatment with a generic AED in monotherapy or in association is acceptable; 3) not exchanging generic AED from different pharmaceutical companies; 4) explaining to the patient the rules governing the authorization of generics and the importance of avoiding exchanges between different generic AED; and 5) if there is some worsening of the clinical condition or side effects appear following the introduction of a generic, the causes must be investigated and communicated to the bodies responsible for pharmacovigilance.
Cañadillas-Hidalgo
F M
FM
Servicio de Neurología, Hospital Universitario Reina Sofía, Córdoba, España. fcanadillash41050@yahoo.es
Sánchez-Alvarez
J C
JC
Serrano-Castro
P J
PJ
Mercadé-Cerdá
J M
JM
D006801:Humans; D000927:Anticonvulsants / Q000191:economics / Q000627:therapeutic use; D032921:Consensus; D016208:Databases, Factual; D011307:Drug Prescriptions / Q000191:economics; D016568:Drugs, Generic / Q000191:economics / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy / Q000191:economics; D016896:Treatment Outcome
D000927:Anticonvulsants; D016568:Drugs, Generic